Barakol, a natural anxiolytic inhibits striatal dopamine release but not uptake in vitro

European Journal of Pharmacology

Volumn 319, Issue 2-3, 1997, Pages 157-164

  Thongsaard, Watchareewan ^a   Pongsakorn, Sakol ^b   Sudsuang, Ratree ^c   Bennett, Geoffrey W ^a   Kendall, David A ^a   Marsden, Charles A ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Barakol; Cassia siamea; Dopamine release; Dopamine uptake, in vitro; Striatum, rat

Indexed keywords

BARAKOL; DOPAMINE RECEPTOR STIMULATING AGENT; ETICLOPRIDE; PERGOLIDE MESILATE; QUINELORANE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINE UPTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ANXIETY AGENTS; BENZOPYRANS; CALCIUM; CASSIA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE AGONISTS; ELECTROCHEMISTRY; MALE; NEOSTRIATUM; PERGOLIDE; PHENALENES; PLANT EXTRACTS; PLANTS, MEDICINAL; POTASSIUM; RATS; RECEPTORS, DOPAMINE D2;

EID: 0031032513     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00850-3     Document Type: Article

References (34)

1. Arunlakshana, O., 1949, Pharmacological study of the levels of Cassia siamea, Siriraj Hosp. Gaz. 1, 434-444.
2. Baldo, B.A. and A.E. Kelley, 1991, Cross-sensitisation between cocaine and GBR-12909, a dopamine uptake inhibitor, Brain Res. Bull. 27, 105-108.
3. Bennett, G.W., T. Sharp, C.A. Marsden and T.L. Parker, 1983, A manually-operated brain tissue slicer suitable for neurotransmitter release studies, J. Neurosci. Methods 7, 107-115.
4. Bycroft, B.W., A. Hassanali-Walji, A.W. Johnson and T.J. King, 1970, The structure and synthesis of barakol: a novel dioxaphenalene derivative from Cassia siamea, J. Chem. Soc. 12, 1686-1689.
5. Chaichantipyuth, C., 1979, A phytochemical study of the leaves of Cassia siamea and Cassia spectabilis, A thesis submitted for the degree of Master of Science in Pharmacy, Chulalongkorn University, Bangkok.
6. Colpaert, F.C., T.F. Meert, C.J.E. Niemegeers and P.A.J. Janssen, 1985, Behaviour and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat, Psychopharmacology 86, 45-54.
7. Cooper, J.R., F.E. Bloom and R.H. Roth, eds., 1991, Dopamine, in: The Biochemical Basis of Neuropharmacology (Oxford University Press, Oxford), pp. 285-337.
8. Ebstein, R.P., K. Seamon, C.R. Creveling and J.W. Daly, 1982, Release of norepinephrine from brain vesicular preparations: effects of an adenylate cyclase activator, forskolin and a phosphodiesterase inhibitor, Cell Mol. Neurobiol. 2, 179-192.
9. File, S.E., 1987, The contribution of behavioural studies to the neuropharmacology of anxiety, Neuropharmacology 26, 877-886.
10. 2 dopaminergic agonist, J. Pharmacol. Exp. Ther. 250, 227-235.
11. 2-like receptor family, Neurotransmission XI, 1-12.
12. Galloway, M.P., 1988, Neurochemical interactions of cocaine with dopaminergic system, Trends Pharmacol. Sci. 9, 451-454.
13. 2 receptors in the rat brain, Eur. J. Pharmacol. 111, 191-197.
14. Handley, S.L. and S. Mithani, 1984, Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of fear-motivated behaviour, Naunyn-Schmiedeberg's Arch. Pharmacol. 327, 11-15.
15. Hassanali-Walji, A., T.J. King and S.C. Wallwork, 1969, Barakol, a novel dioxaphenalene derivative from Cassia siamea, J. Chem. Soc. Chem. Commun. 12, 678.
16. Herdon, H., J. Strupish and S.R. Nahorski, 1985, Difference between the release of radiolabelled and endogenous dopamine from superfused rat brain slices: effects of depolarising stimuli, amphetamine and synthesis inhibition, Brain Res. 348, 309-320.
17. Heikkila, R.E. and L. Manzino, 1984, Behaviour properties of GBR-12909, GBR-13069 and GBR-13098: specific inhibitors of dopamine uptake, Eur. J. Pharmacol. 103, 241-248.
18. Kinghorn, A.D. and M.F. Balandrin, 1992, Human Medicinal Agents from Plants (American Chemical Society, Washington, DC).
19. Kiyatkin, E.A., 1995, Functional significance of mesolimbic dopamine, Neurosci. Biobehav. Rev. 19, 573-598.
20. Langtry, H.D. and S.P. Clissold, 1990, Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease, Drugs 39, 491-506.
21. Mokasmit, M., 1981, Hypertensive effects of Thai medicinal plants, Newslett. Natl. Res. Council Thailand 22, 3-4.
22. Nakachi, N., Y. Kiuchi, M. Inagaki, M. Inazu, Y. Yamazaki and K. Oguchi, 1995, Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats, Eur. J. Pharmacol. 281, 195-203.
23. Pahwa, R. and W.C. Koller, 1995, Dopamine agonists in the treatment of Parkinson's disease, Cleveland Clin. J. Med. 62, 212-217.
24. Pellow, S., P. Chopin, M. Briley and S.E. File, 1985, The validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat, J. Neurosci. Methods 14, 149-167.
25. Rowlett, J.K., B.A. Mattingly and M.T. Bardo, 1995, Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists, Synapse 20, 209-216.
26. Satyavati, G.V., M.K. Raona and M. Sharma, 1979, Medicinal Plants of India (Indian Council of Medicinal Research, New Delhi).
27. Suwan, G., R. Sudsuang, P. Dhumma-Upakorn and C. Werawong, 1992, Hypertensive effects of barakol extracted from leaves of Cassia siamea Lam. in rats and cats, Thai J. Physiol. Sci. 5, 53-65.
28. Thongsaard, W., G.W. Bennett, C.A. Marsden, 1995a, Barakol inhibits striatal dopamine release in vitro, Br. J. Pharmacol. 116, 383P.
29. Thongsaard, W., C. Deachapunya, S. Pongsakorn, E.A. Boyd, G.W. Bennett and C.A Marsden, 1995b, The dioxaphenalene derivative barakol extracted from Cassia siamea: a natural anxiolytic?, Br. J. Pharmacol. 114, 284P.
30. Thongsaard, W., C. Deachapunya, S. Pongsakorn, E.A. Boyd, G.W. Bennett and C.A. Marsden, 1996a, Barakol - a potential anxiolytic extracted from Cassia siamea, Pharmacol. Biochem. Behav. 53, 753-758.
31. Thongsaard, W., D.A. Kendall, G.W. Bennett and C.A. Marsden, 1996b, A simple method for measuring dopamine release from rat brain slices, J. Pharmacol. Toxicol. Methods (submitted).
32. Thongsaard, W., S. Pongsakorn, R. Sudsuang, G.W. Bennett and C.A. Marsden, 1996c, Effect of barakol on extracellular dopamine and its metabolites in rat striatum in vivo, in: Proceedings of the 7th International Conference on in vivo Methods; Monitoring Molecules in Neuroscience, Santa Cruz do Tenerife, Spain, pp. 127-128.
33. Tongroach, P., P. Jantarayota, B. Tantisira, P. Kunluan, C. Tongroach and C. Chaichantipyuth, 1992, Barakol, a neuroactive compound from Cassia siamea, in: Proceedings of the First JSPS-NRCT Joint Seminar in Pharmaceutical Sciences; Advance in Research on Pharmacologically Active Substances from Natural Sources, Chiangmai, Thailand, p. OP21.
34. Tyler, C.B. and M.P. Galloway, 1992, Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields, J. Pharmacol. Exp. Ther. 261, 567-573.